Get the Stockscreener App
7.21
0.00%
0.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Zynex Inc stock is traded at $7.21, with a volume of 28,639.
It is up +0.00% in the last 24 hours and down -6.73% over the past month.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$7.21
Open:
$7.26
24h Volume:
28,639
Relative Volume:
0.42
Market Cap:
$228.01M
Revenue:
$193.67M
Net Income/Loss:
$4.82M
P/E Ratio:
51.39
EPS:
0.1403
Net Cash Flow:
$15.53M
1W Performance:
-2.04%
1M Performance:
-6.73%
6M Performance:
-8.62%
1Y Performance:
-41.38%
1-Day Range:
$7.095
$7.34
1-Week Range:
$7.095
$7.58
52-Week Range:
$7.095
$13.19
Zynex Inc Stock (ZYXI) Company Profile
Name
Zynex Inc
Sector
Industry
Phone
(800)-495-6670
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Compare ZYXI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 9.30 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1925 | 427.35M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.80 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.33 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.55 | 114.12M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.97 | 52.03M | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-23 | Initiated | RBC Capital Mkts | Outperform |
| Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-28-22 | Reiterated | B. Riley Securities | Buy |
| Jul-16-21 | Upgrade | B. Riley Securities | Neutral → Buy |
| Mar-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Feb-26-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-28-21 | Downgrade | Northland Capital | Outperform → Market Perform |
| Sep-14-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-09-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-29-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jul-20-20 | Initiated | Piper Sandler | Overweight |
| Jul-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-19-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-01-20 | Initiated | Northland Capital | Outperform |
| Sep-23-19 | Initiated | H.C. Wainwright | Buy |
View All
Zynex Inc Stock (ZYXI) Latest News
Zynex stock touches 52-week low at $7.12 amid market challenges - Investing.com India
Zynex stock touches 52-week low at $7.12 amid market challenges By Investing.com - Investing.com South Africa
Zynex Sets Fourth Quarter and Year End 2024 Earnings Call - Quantisnow
(ZYXI) Trading Advice - Stock Traders Daily
Zynex COO on pain management innovations and growth plans – ICYMI - Proactive Investors UK
Zynex COO highlights strong reimbursement strategy and growth in non-opioid pain management - Proactive Investors USA
Zynex Inc to Host Earnings Call - ACCESS Newswire
Zynex (ZYXI) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Zynex (ZYXI) Projected to Post Earnings on Wednesday - Defense World
Critical Contrast: NeurAxis (NASDAQ:NRXS) & Zynex (NASDAQ:ZYXI) - Defense World
ZYXI INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Possible Securities Law Violations - ACCESS Newswire
Trading (ZYXI) With Integrated Risk Controls - Stock Traders Daily
Insider Selling: Zynex, Inc. (NASDAQ:ZYXI) CFO Sells 10,000 Shares of Stock - MarketBeat
Janney Montgomery Scott LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Pelvic Electro-Stimulators Market Booming Demand: Future - openPR
Insider Sell: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com
CHIEF FINANCIAL OFFICER Moorhead Daniel J sold $76,800 worth of shares (10,000 units at $7.68), decreasing direct ownership by 34% to 19,738 units (SEC Form 4) - Quantisnow
Zynex, Inc. (NASDAQ:ZYXI) Shares Purchased by JPMorgan Chase & Co. - Defense World
ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN
Zynex eyes FDA submission for NiCO oximeter as it expands portfolio of innovative medical devices - Proactive Investors USA
Zynex Completes Its Laser Pulse Oximetry Trial - MPO-mag
Returns On Capital Signal Tricky Times Ahead For Zynex (NASDAQ:ZYXI) - Yahoo Finance
Barclays PLC Has $236,000 Holdings in Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Electrotherapy System Market Growth in Future Scope 2025-2032 | - openPR
Jane Street Group LLC Acquires 1,929 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
(ZYXI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Zynex to Present at the H.C. Wainwright Global Investment Conference - GuruFocus.com
Geode Capital Management LLC Has $3.47 Million Position in Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Muscle Stimulation Devices Market Overall Study Report - openPR
Barclays PLC Acquires 8,713 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Electrotherapy System Market Detailed In New Research Report - openPR
Zynex CFO Daniel Moorhead sells $78,800 in common stock By Investing.com - Investing.com Australia
Zynex CFO Daniel Moorhead sells $78,800 in common stock - Investing.com India
Daniel J. Moorhead Sells 10,000 Shares of Zynex, Inc. (NASDAQ:ZYXI) Stock - MarketBeat
CHIEF FINANCIAL OFFICER Moorhead Daniel J sold $78,800 worth of shares (10,000 units at $7.88), decreasing direct ownership by 28% to 26,299 units (SEC Form 4) - Quantisnow
State Street Corp Sells 9,172 Shares of Zynex, Inc. (NASDAQ:ZYXI) - Defense World
Zynex Introduces New Products - GuruFocus.com
(ZYXI) Trading Signals - Stock Traders Daily
Electrotherapy System Market Future Business Opportunities - openPR
How to Take Advantage of moves in (ZYXI) - Stock Traders Daily
Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada
Zynex partners with VA to expand pain management access - Investing.com
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada
Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com
Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States – Company AnnouncementFT.com - Financial Times
Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States - PR Newswire
Zynex Inc Stock (ZYXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):